Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide

Author(s): Dan Chen, Shuangyan Yang*, Jie Ding and Ailing Liu

Volume 23, Issue 5, 2023

Published on: 27 July, 2022

Page: [425 - 432] Pages: 8

DOI: 10.2174/1566524022666220513111637

Price: $65

conference banner
Abstract

Background: Preeclampsia is a disorder of hypertension and proteinuria accompanied by abnormal inflammatory responses. Both aspirin and quercetin possess anti-inflammatory and anti-hypertensive properties. A low dose of aspirin is recommended for the prevention of preeclampsia in patients with preeclampsia history. Whether quercetin can enhance the effect of aspirin on preeclampsia remains elusive.

Methods: Female Sprague-Dawley pregnant rats were treated with daily administration of aspirin, quercetin, or a combination of aspirin and quercetin and subsequently received lipopolysaccharides (LPS) injection to induce preeclampsia-like symptoms. The systolic blood pressure and proteinuria from all groups of rats were assessed.

Results: Our results demonstrated that the combination of quercetin and aspirin exerted significantly stronger effects than aspirin alone on decreasing systolic blood pressure and proteinuria, reducing pro-inflammatory cytokine production, and inhibiting M1-type decidual macrophages polarization in an LPS-induced rat model of preeclampsia.

Conclusion: This study suggested that quercetin may serve as an excellent supplement to aspirin in preventing or treating patients with preeclampsia.

Keywords: Preeclampsia, aspirin, quercetin, lipopolysaccharides, macrophages, pathogenesis.

« Previous Next »
[1]
Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ Res 2019; 124(7): 1094-112.
[http://dx.doi.org/10.1161/CIRCRESAHA.118.313276] [PMID: 30920918]
[2]
Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol 2020; 76(14): 1690-702.
[http://dx.doi.org/10.1016/j.jacc.2020.08.014] [PMID: 33004135]
[3]
Xiao Z, Wang Y, Thai PN, Li X, Lu X, Pu J. Mechanisms linking hyperglycemia in pregnancy to the offspring cardiovascular system dysfunction. STEMedicine 2021; 2(7): e91.
[http://dx.doi.org/10.37175/stemedicine.v2i7.91]
[4]
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011; 7: 467-74.
[PMID: 21822394]
[5]
Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs 2017; 77(17): 1819-31.
[http://dx.doi.org/10.1007/s40265-017-0823-0] [PMID: 29039130]
[6]
Ożarowski M, Mikołajczak PL, Kujawski R, et al. Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: Review of in vitro, in vivo, and clinical studies. Evid Based Complement Alternat Med 2018; 20187421489.
[http://dx.doi.org/10.1155/2018/7421489] [PMID: 30622610]
[7]
Dekker GA, Sibai BM. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 1993; 168(1 Pt 1): 214-27.
[http://dx.doi.org/10.1016/S0002-9378(12)90917-5] [PMID: 8420330]
[8]
D’Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia 2015; 106: 256-71.
[http://dx.doi.org/10.1016/j.fitote.2015.09.018] [PMID: 26393898]
[9]
Terao J. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochem Pharmacol 2017; 139: 15-23.
[http://dx.doi.org/10.1016/j.bcp.2017.03.021] [PMID: 28377278]
[10]
Clark JL, Zahradka P, Taylor CG. Efficacy of flavonoids in the management of high blood pressure. Nutr Rev 2015; 73(12): 799-822.
[http://dx.doi.org/10.1093/nutrit/nuv048] [PMID: 26491142]
[11]
Speciale A, Chirafisi J, Saija A, Cimino F. Nutritional antioxidants and adaptive cell responses: An update. Curr Mol Med 2011; 11(9): 770-89.
[http://dx.doi.org/10.2174/156652411798062395] [PMID: 21999148]
[12]
Yang S, Song L, Shi X, Zhao N, Ma Y. Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME. Biomed Pharmacother 2019; 116: 108969.
[http://dx.doi.org/10.1016/j.biopha.2019.108969] [PMID: 31103824]
[13]
Zhang C, Zhu Y, Shen Y, Zuo C. Aspirin ameliorates preeclampsia induced by a peroxisome proliferator-activated receptor antagonist. Reprod Sci 2018; 25(12): 1655-62.
[http://dx.doi.org/10.1177/1933719118756746] [PMID: 29439623]
[14]
Sun J, Zhang H, Liu F, Tang D, Lu X. Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway. Can J Physiol Pharmacol 2018; 96(11): 1084-91.
[http://dx.doi.org/10.1139/cjpp-2018-0087] [PMID: 29969574]
[15]
Xu Q, Liu LZ, Qian X, et al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 2012; 40(2): 761-74.
[http://dx.doi.org/10.1093/nar/gkr730] [PMID: 21917858]
[16]
Xu Q, Jiang Y, Yin Y, et al. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol 2013; 5(1): 3-13.
[http://dx.doi.org/10.1093/jmcb/mjs049] [PMID: 22935141]
[17]
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017; 2: 2.
[http://dx.doi.org/10.1038/sigtrans.2017.23] [PMID: 29158945]
[18]
Lash GE, Pitman H, Morgan HL, Innes BA, Agwu CN, Bulmer JN. Decidual macrophages: Key regulators of vascular remodeling in human pregnancy. J Leukoc Biol 2016; 100(2): 315-25.
[http://dx.doi.org/10.1189/jlb.1A0815-351R] [PMID: 26819320]
[19]
Moffett A, Hiby SE. How Does the maternal immune system contribute to the development of pre-eclampsia? Placenta 2007; 28(Suppl A): S51-56.
[http://dx.doi.org/10.1016/j.placenta.2006.11.008]
[20]
Fricke EM, Elgin TG, Gong H, et al. Lipopolysaccharide-induced maternal inflammation induces direct placental injury without alteration in placental blood flow and induces a secondary fetal intestinal injury that persists into adulthood. Am J Reprod Immunol 2018; 79(5): e12816.
[http://dx.doi.org/10.1111/aji.12816] [PMID: 29369434]
[21]
Gaspoz JM, Coxson PG, Goldman PA, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2002; 346(23): 1800-6.
[http://dx.doi.org/10.1056/NEJM200206063462309] [PMID: 12050341]
[22]
Cadavid AP. Aspirin: The mechanism of action revisited in the context of pregnancy complications. Front Immunol 2017; 8: 261.
[http://dx.doi.org/10.3389/fimmu.2017.00261] [PMID: 28360907]
[23]
Serban MC, Sahebkar A, Zanchetti A, et al. Effects of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016; 5(7): 5.
[http://dx.doi.org/10.1161/JAHA.115.002713] [PMID: 27405810]
[24]
Brüll V, Burak C, Stoffel-Wagner B, et al. Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: A randomized, double-blind, placebo-controlled, crossover trial. Eur J Nutr 2017; 56(3): 1347-57.
[http://dx.doi.org/10.1007/s00394-016-1185-1] [PMID: 26924303]
[25]
Vanhees K, Godschalk RW, Sanders A, van Doorn SB, van Schooten FJ. Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood. Toxicology 2011; 290(2-3): 350-8.
[http://dx.doi.org/10.1016/j.tox.2011.10.017] [PMID: 22064046]
[26]
Prater MR, Laudermilch CL, Liang C, Holladay SD. Placental oxidative stress alters expression of murine osteogenic genes and impairs fetal skeletal formation. Placenta 2008; 29(9): 802-8.
[http://dx.doi.org/10.1016/j.placenta.2008.06.010] [PMID: 18675455]
[27]
Liu W, Zhang M, Feng J, Fan A, Zhou Y, Xu Y. The influence of quercetin on maternal immunity, oxidative stress, and inflammation in mice with exposure of fine particulate matter during gestation. Int J Environ Res Public Health 2017; 14(6): 14.
[http://dx.doi.org/10.3390/ijerph14060592] [PMID: 28574437]
[28]
Calabró V, Litterio MC, Fraga CG, Galleano M, Piotrkowski B. Effects of quercetin on heart nitric oxide metabolism in l-NAME treated rats. Arch Biochem Biophys 2018; 647: 47-53.
[http://dx.doi.org/10.1016/j.abb.2018.03.041] [PMID: 29621523]
[29]
Galindo P, González-Manzano S, Zarzuelo MJ, et al. Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats. Food Funct 2012; 3(6): 643-50.
[http://dx.doi.org/10.1039/c2fo10268d] [PMID: 22441211]
[30]
Galisteo M, García-Saura MF, Jiménez R, et al. Effects of quercetin treatment on vascular function in deoxy-corticosterone acetate-salt hypertensive rats. Comparative study with verapamil. Planta Med 2004; 70(4): 334-41.
[http://dx.doi.org/10.1055/s-2004-818945] [PMID: 15095149]
[31]
Li Q, Yin L, Si Y, Zhang C, Meng Y, Yang W. The bioflavonoid quercetin improves pathophysiology in a rat model of preeclampsia. Biomed Pharmacother 2020; 127110122.
[http://dx.doi.org/10.1016/j.biopha.2020.110122] [PMID: 32305698]
[32]
Svensson-Arvelund J, Ernerudh J, Buse E, et al. The placenta in toxicology. Part II: Systemic and local immune adaptations in pregnancy. Toxicol Pathol 2014; 42(2): 327-38.
[http://dx.doi.org/10.1177/0192623313482205] [PMID: 23531796]
[33]
Bulmer JN, Morrison L, Smith JC. Expression of class II MHC gene products by macrophages in human uteroplacental tissue. Immunology 1988; 63(4): 707-14.
[PMID: 3284818]
[34]
Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol 2010; 54(2-3): 281-94.
[http://dx.doi.org/10.1387/ijdb.082763jb] [PMID: 19876837]
[35]
Svensson J, Jenmalm MC, Matussek A, Geffers R, Berg G, Ernerudh J. Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol 2011; 187(7): 3671-82.
[http://dx.doi.org/10.4049/jimmunol.1100130] [PMID: 21890660]
[36]
Abumaree MH, Chamley LW, Badri M, El-Muzaini MF. Trophoblast debris modulates the expression of immune proteins in macrophages: A key to maternal tolerance of the fetal allograft? J Reprod Immunol 2012; 94(2): 131-41.
[http://dx.doi.org/10.1016/j.jri.2012.03.488] [PMID: 22542910]
[37]
Yao Y, Xu XH, Jin L. Macrophage polarization in physiological and pathological pregnancy. Front Immunol 2019; 10: 792.
[http://dx.doi.org/10.3389/fimmu.2019.00792] [PMID: 31037072]

Rights & Permissions Print Cite
Article Metrics
6
© 2024 Bentham Science Publishers | Privacy Policy